Literatur
-
1
Faubion Jr. W A, Loftus Jr. E V, Harmsen W S. et al .
The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study.
Gastroenterology.
2001;
121
255-260
-
2
Ewe K, Press A G, Singe C C. et al .
Azathioprine combined with prednisolone or monotherapy with prednisolone in active Crohn’s disease.
Gastroenterology.
1993;
105
367-372
-
3
Candy S, Wright J, Gerber M. et al .
A controlled double blind study of azathioprine in the management of Crohn’s disease.
Gut.
1995;
37
674-678
-
4
Stallmach A, Hagel S, Bruns T.
Adverse effects of biologics used for treating IBD.
Best Pract Res Clin Gastroenterol.
2010;
24
167-182
Prof. Dr. Andreas Stallmach
Klinik für Innere Medizin II
Universitätsklinikum Jena
Erlanger Allee 101
07747 Jena
Email: andreas.stallmach@med.uni-jena.de